A study of the virulence in mice of high copying fidelity variants of human enterovirus 71

Virus Research

Volumn 176, Issue 1-2, 2013, Pages 265-272

  Sadeghipour, Sara ^a   McMinn, Peter C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENTEROVIRUS 71; INFECTION; MOUSE; MUTATION; MYOSITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; SURVIVAL TIME; VIRULENCE; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALIA; HUMAN ENTEROVIRUS 71; MUS;

EID: 84881378030     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.06.019     Document Type: Article

References (25)

1. Castro C., Smidansky E.D., Arnold J.J., Maksimchuk K.R., Moustafa I., Uchida A., Gotte M., Konigsburg W., Cameron C.E. Nucleic acid polymerases use a general acid for nucleotidyl transfer. Nature Structural Biology 2009, 16(2):212-218.
2. Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., McMinn P.C. The molecular basis of mouse adaptation by human enterovirus 71. Journal of General Virology 2008, 89(7):1622-1632.
3. Coffey L.L., Vignuzzi M. Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures. Journal of Virology 2011, 85(2):1025-1035.
4. Gnädig N.F., Beaucourt S., Campagnola G., Bordería A.V., Sanz-Ramos M., Gong P., Blanc H., Peersen O.B., Vignuzzi M. Coxsackievirus B3 mutator strains are attenuated in vivo. Proceedings of the National Academy of Sciences 2012, 109(34):E2294-E2303.
5. Graham R., Becker M., Eckerle L., Bolles M., Denison M., Baric R. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nature Medicine 2012, 18(12):1820-1826.
6. Knowles N.J., Hovi T., Hyypiä T., King A.M.Q., Lindberg A.M., Allansch M.A., Palmenberg A.C., Immonds P., Kern T., Stanway G., Yamashita T., Zell R. Picornaviridae. Virus Taxonomy: Classification and Nomenclature of Viruses 2012, Elsevier, San Diego.
7. Liu J., Dong W., Quan X., Ma C., Qin C., Zhang L. Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Archives of Virology 2012, 157(3):539-543.
8. McMinn P. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiology Review 2002, 26(1):91-107.
9. McMinn P., Stratov I., Nagarajan L., Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in western Australia. Clinical Infectious Diseases 2001, 32(2):236-242.
10. Nagata N., Shimizu H., Ami Y., Tano Y., Harashima A., Suzaki Y., Sato Y., Miyamura T., Sata T., Iwasaki T. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. Journal of Medical Virology 2002, 67(2):207-216.
11. Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nature Medicine 2009, 15(7):794-797.
12. Pfeiffer J.K., Kirkegaard K. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proceedings of the National Academy of Sciences 2003, 100(12):7289-7294.
13. Pfeiffer J.K., Kirkegaard K. Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathogens 2005, 1(2):e11.
14. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 1938, 27(3):493-497.
15. Ren R., Costantini F., Gorgacz E.J., Lee J.J., Racaniello V.R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 1990, 63(2):353-362.
16. Sadeghipour S., Bek E.J., McMinn P.C. Ribavirin-resistant mutants of human enterovirus 71 express a high replication fidelity phenotype during growth in cell culture. Journal of Virology 2013, 87(3):1759-1769.
17. Sanz-Ramos M., Díaz-San Segundo F., Escarmís C., Domingo E., Sevilla N. Hidden virulence determinants in a viral quasispecies in vivo. Journal of Virology 2008, 82(21):10465-10476.
18. Sanz-Ramos M., Rodríguez-Calvo T., Sevilla N. Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population. PLoS ONE 2012, 7(6):e39941.
19. Vignuzzi M., Stone J.K., Arnold J.J., Cameron C.E., Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 2006, 439(7074):344-348.
20. Vignuzzi M., Wendt E., Andino R. Engineering attenuated virus vaccines by controlling replication fidelity. Nature Medicine 2008, 14(2):154-161.
21. Weeks S.A., Lee C.A., Zhao Y., Smidansky E.D., August A., Arnold J.J., Cameron C.E. A polymerase mechanism-based strategy for viral attenuation and vaccine development. Journal of Biological Chemistry 2012, 287(38):31618-31622.
22. Wright A.J., Phillpotts R.J. Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection of mice. Archives of Virology 1998, 143(6):1155-1162.
23. Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nature Medicine 2009, 15(7):798-801.
24. Zaini Z., McMinn P. A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype. Journal of General Virology 2012, 93(Pt 9):1935-1940.
25. Zaini Z., Phuektes P., McMinn P. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. Virus Research 2012, 167(1):86-96.